Menu

  • Donate
  • Warriors
  • Chapters
  • Events
  • News
  • Brain Tumors
    • About Brain Tumors
    • Brain Tumor Symptoms
    • Brain Tumor Facts
  • Family Support
    • Warrior Program
    • Families Helping Families
    • Financial Support
  • How to Help
    • Get Involved
    • Ways to Give
    • Fundraise
    • Partnerships
    • Employer Match
    • Payroll Giving
    • Attend an Event
    • Awareness Page
    • Promising Pathway Act
    • Shop
  • Research
    • Research & Grants
    • DIPG/DMG Collaborative
  • Who We Are
    • Our Mission
    • Our History
    • Our Success
    • Our Chapters
    • Financials
    • The Councils
    • Staff
    • Contact Us
           
Logo
Logo
  • Warriors
  • Chapters
  • Events
  • Donate
  • Brain Tumors
    • About Brain Tumors
    • Brain Tumor Symptoms
    • Brain Tumor Facts
  • Family Support
    • Warrior Program
    • Families Helping Families
    • Financial Support
  • How to Help
    • Get Involved
    • Ways to Give
    • Fundraise
    • Partnerships
    • Employer Match
    • Payroll Giving
    • Attend an Event
    • Awareness Page
    • Promising Pathway Act
    • Shop
  • Research
    • Research & Grants
    • DIPG/DMG Collaborative
  • Who We Are
    • Our Mission
    • Our History
    • Our Success
    • Our Chapters
    • Financials
    • The Councils
    • Staff
    • Contact Us

Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

Grant Approval Process

Grant Approval Process


The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.





  • 9
  • 10
  • 11
  • 12
  • 13
  • 14

Dana Farber Cancer Institute - $82,863

Amount
$82,863.00 USD
Date
December 2015

Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma

Grant Information

VU University Medical Center - $92,950

Amount
$92,950.00 USD
Date
November 2015

Liquid Biopsies for the Monitoring of Diffuse Intrinsic Pontine Glioma.

Grant Information

Children's Cancer Institute - $145,341 USD / $176,778 AUD (Approx)

Amount
$145,341.00 USD
Date
November 2015

Fenretinide, a novel agent targeting RTK/PI3K/AKT network for the treatment of Diffuse Intrinsic Pontine Glioma.

Grant Information

Cincinnati Children's Hospital Medical Center - $200,000

Amount
$200,000.00 USD
Date
October 2015

Intra-tumoral heterogeneity in diffuse intrinsic pontine and midline high-grade gliomas

Grant Information

The Hospital for Sick Children - $190,905

Amount
$190,905.00 USD
Date
October 2015

Mitochondrial DNA alterations and their potential as a novel therapeutic target in DIPG

Grant Information

Children's National Medical Center - $200,000

Amount
$200,000.00 USD
Date
October 2015

Evaluating TORC1/2 kinase inhibition in murine and nonhuman primate (NHP) models

Grant Information

European DIPG Registry - $445,870.12

Amount
$445,870.00 USD
Date
September 2015

European DIPG Registry.

Grant Information

Institute of Cancer Research - $99,470

Amount
$99,470.00 USD
Date
September 2015

The Evolutionary Dynamics of Diffuse Intrinsic Pontine Glioma.

Grant Information

Stanford University Medical Center - $200,000

Amount
$200,000.00 USD
Date
September 2015

Targeting neuronal activity-regulated DIPG infiltration

Grant Information

International DIPG Registry - $699,935

Amount
$699,935.00 USD
Date
August 2015

Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry

Grant Information

Ann & Robert H. Lurie Children’s Hospital of Chicago - $50,000

Amount
$50,000.00 USD
Date
April 2015

Increased Tenascin-C (TNC) protein expression in tumor tissue and CSF in DIPG patients

Grant Information

Stanford University - $50,000

Amount
$50,000.00 USD
Date
April 2015

Tumor Associated Microglia in Diffuse Intrinsic Pontine Glioma

Grant Information

Children's Cancer Institute - $81,683 USD / $103,615 AUD (Approx)

Amount
$81,683.00 USD
Date
February 2015

Facilitates Chromatin Transcription Complex (FACT): A novel therapeutic target against Diffuse Intrinsic Pontine Glioma.

Grant Information

Cincinnati Children's Hospital Medical Center - $100,000

Amount
$100,000.00 USD
Date
February 2015

Epigenetic alterations as therapeutic targets in pediatric brain tumors

Grant Information

Cincinnati Children's Hospital - $176,186

Amount
$176,186.00 USD
Date
November 2014

International DIPG Registry

Grant Information
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14

Donate Today & Become A Hero

Donate
The Cure Starts Now Logo
See The Impact
Warriors
Who We Are
Get Involved
Contact Us
Donate
Find A Chapter

Candid Great Nonprofits Charity Navigator DIPG/DMG Collaborative Foundational Partner
           
Brain Tumors
  • About Brain Tumors
  • Brain Tumor Symptoms
  • Brain Tumor Facts
Family Support
  • Warrior Program
  • Families Helping Families
  • Financial Support
How to Help
  • Get Involved
  • Ways to Give
  • Fundraise
  • Partnerships
  • Employer Match
  • Payroll Giving
  • Attend an Event
  • Awareness Page
  • Promising Pathway Act
  • Shop
Research
  • Research & Grants
  • DIPG/DMG Collaborative
Who We Are
  • Our Mission
  • Our History
  • Our Success
  • Our Chapters
  • Financials
  • The Councils
  • Staff
  • Contact Us
Contact Us
  •                

  • Candid Great Nonprofits Charity Navigator DIPG/DMG Collaborative Foundational Partner

The Cure Starts Now Cancer Resource Network:
The Cure Starts Now | DIPG.org | Medulloblastoma.org

© 2026 The Cure Starts Now | 10280 Chester Road, Cincinnati, Ohio 45215 | 513-772-4888 | Privacy Policy
Registered 501(c)(3) | FEIN: 26-0269131